journal article·2020-06-03

Antibacterial Effects of Bimetallic Clusters Incorporated in Amorphous Carbon for Stent Application

Isabel Carvalho, Nicolina Dias, Mariana Henriques, Sebastian Calderon V, Paulo Ferreira, Albano Cavaleiro, Sandra Carvalho

ACS Applied Materials & Interfaces· Volume 12· Issue 22
Publisher page

Abstract

The purpose of this work is the development of Ag/a:C and Ag-Au/a:C coatings for ureteral stents, to provide them with antimicrobial characteristics. Silver was selected because of its well-known antibacterial properties, while gold was included to assess its capacity to accelerate the silver ion release forming a galvanic couple between Au and Ag. Thus, the metallic (Ag) and bimetallic clusters (Ag-Au) were produced by three different configurations: (i) unbalanced magnetron sputtering (conventional sputtering), (ii) plasma gas condensation process, and by (iii) a combination between both previous approaches. Coatings with Ag-Au bimetallic clusters were characterized by transmission electron microscopy (TEM) in order to study the arrangement (alloy, core-shell, and galvanic couple) of these particles in the carbon matrix. Inductively coupled plasma optical emission spectroscopy (ICP-OES) was used to quantify the Ag ions released through artificial urine from the different coatings deposited on thermoplastic polyurethane tape (one of the materials used in the manufacture of the ureteral stent ). Then, the antibacterial and cytotoxicity properties of Ag and Ag-Au/a:C coatings were evaluated. TEM shows that a biphasic structure was not detected, thus not allowing to anticipate the establishment of a galvanic couple. The ICP-OES results demonstrate that the silver ionization is mainly a function of the amount of silver incorporated in the amorphous carbon (a:C) matrix, and the formation of a bimetallic alloy has a detrimental effect on release of the silver ions. The antibacterial activity was regulated by the silver ionization mechanisms because the coatings with higher Ag release had a higher antibacterial activity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Infectious Aortic and Vascular Conditions · Ureteral procedures and complications · Dialysis and Renal Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

SEG-CEMMPRE Mechanical Engineering Department, University of Coimbra, 3030-788 Coimbra, Portugal

CEB, Centre of Biological Engineering, LIBRO—Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal

CFUM-UP, Centro de Física das Universidades do Minho e do Porto, University of Minho, Campus of Azurém, 4800-058 Guimarães, Portugal

CEB, Centre of Biological Engineering, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal

INL—International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga s/n, 4715-330 Braga, Portugal

Mechanical Engineering Department and IDMEC, Instituto Superior Técnico, University of Lisbon, Av. Rovisco Pais, 1049-001 Lisboa, Portugal

Materials Science and Engineering Program and Department of Mechanical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States

IPN-LED & MAT Instituto Pedro Nunes, Laboratory for Wear, Testing & Materials, Rua Pedro Nunes, 3030-199 Coimbra, Portugal

Funding

European Regional Development Fund · Funda??o para a Ci?ncia e a Tecnologia

References (35)

Show source-provided references
1. 10.3389/fchem.2019.0043110.3389/fchem.2019.00431 ↗
2. 10.1080/1040841X.2016.124065610.1080/1040841X.2016.1240656 ↗
3. 10.1016/S0924-8579(00)00360-510.1016/S0924-8579(00)00360-5 ↗
4. 10.1016/j.msec.2016.04.10310.1016/j.msec.2016.04.103 ↗
5. 10.1016/j.jcma.2011.08.01710.1016/j.jcma.2011.08.017 ↗
6. 10.1007/s00240-010-0280-710.1007/s00240-010-0280-7 ↗
7. 10.1016/j.apmt.2016.07.00610.1016/j.apmt.2016.07.006 ↗
8. 10.1111/iju.1411910.1111/iju.14119 ↗
9. 10.1016/j.urology.2015.07.00610.1016/j.urology.2015.07.006 ↗
10. 10.1007/s10096-015-2323-z10.1007/s10096-015-2323-z ↗
11. 10.1186/s40168-019-0674-x10.1186/s40168-019-0674-x ↗
12. 10.4414/smw.2017.1440810.4414/smw.2017.14408 ↗
13. 10.1089/end.2007.990410.1089/end.2007.9904 ↗
14. 10.1016/j.juro.2009.05.00810.1016/j.juro.2009.05.008 ↗
15. 10.1089/end.2007.021810.1089/end.2007.0218 ↗
16. 10.1016/j.juro.2007.01.01610.1016/j.juro.2007.01.016 ↗
17. 10.1016/j.ajur.2015.08.00610.1016/j.ajur.2015.08.006 ↗
18. 10.1016/S0924-8579(02)00091-210.1016/S0924-8579(02)00091-2 ↗
19. 10.1016/j.diamond.2008.02.02710.1016/j.diamond.2008.02.027 ↗
20. 10.1016/S0925-9635(03)00081-510.1016/S0925-9635(03)00081-5 ↗
21. 10.1016/j.diamond.2018.03.03510.1016/j.diamond.2018.03.035 ↗
22. 10.1016/j.tsf.2018.02.01510.1016/j.tsf.2018.02.015 ↗
23. 10.1016/j.apsusc.2016.03.11310.1016/j.apsusc.2016.03.113 ↗
24. 10.1016/j.ijantimicag.2018.03.01510.1016/j.ijantimicag.2018.03.015 ↗
25. 10.1016/j.biomaterials.2013.01.07410.1016/j.biomaterials.2013.01.074 ↗
26. 10.1016/j.ijantimicag.2009.01.01710.1016/j.ijantimicag.2009.01.017 ↗
27. 10.1016/j.msec.2016.12.07510.1016/j.msec.2016.12.075 ↗
28. 10.1016/j.msec.2014.10.05810.1016/j.msec.2014.10.058 ↗
29. 10.1016/S0257-8972(02)00689-810.1016/S0257-8972(02)00689-8 ↗
30. 10.1002/ppap.20130017510.1002/ppap.201300175 ↗
31. 10.1016/j.tsf.2018.12.01010.1016/j.tsf.2018.12.010 ↗
32. 10.1016/j.surfcoat.2011.09.05910.1016/j.surfcoat.2011.09.059 ↗
33. 10.1093/ajcp/45.4_ts.49310.1093/ajcp/45.4_ts.493 ↗
34. 10.3109/21691401.2014.95363210.3109/21691401.2014.953632 ↗
35. 10.1021/nn800531q10.1021/nn800531q ↗